ArticleAnnals of translational medicine2023
Recurrent ventricular tachycardia in a patient with COVID-19 vaccine-associated myocarditis: a case report.
Article in Annals of translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.
- Assessing the Risk of Myocarditis Post-COVID-19 Vaccination: A Systematic Review of Case Reports from 2023 to 2025.Cardiovascular toxicology · 2026Pooled it
- Syncopes, paresis and loss of vision after COVID-19 mRNA-based vaccination and SARS-CoV-2 infection.Infection · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The development of coronavirus disease 2019 (COVID-19) vaccine-associated myocarditis has been reported. Most of the reported cases are mild, with quick clinical recovery and excellent short-term outcomes. Cases of COVID-19 vaccine-associated myocarditis presenting with sustained ventricular tachycardia (VT) are rare. Case Description: A 46-year-old male patient with no prior cardiac history presented following two episodes of syncope. Two days earlier, he had received his second dose of COVID-19 mRNA vaccine (Pfizer)-first dose was administered three weeks earlier. He had an episode of VT while in the emergency room. His cardiac magnetic resonance imaging (MRI) findings were consistent with myocarditis. He was eventually diagnosed with COVID-19 vaccine-associated myocarditis after all other work up were unremarkable [echocardiogram, coronary angiogram, diagnostic electrophysiology study and later Conclusions: Excellent short-term outcomes have been reported in patients with COVID-19 vaccine associated myocarditis. Our case shows that long-term outcomes may not be benign in everyone, particularly in those who develop myocardial scar.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.